Y Takada

922 total citations
32 papers, 743 citations indexed

About

Y Takada is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Y Takada has authored 32 papers receiving a total of 743 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pulmonary and Respiratory Medicine, 18 papers in Oncology and 7 papers in Surgery. Recurrent topics in Y Takada's work include Lung Cancer Research Studies (14 papers), Lung Cancer Treatments and Mutations (13 papers) and Cancer therapeutics and mechanisms (7 papers). Y Takada is often cited by papers focused on Lung Cancer Research Studies (14 papers), Lung Cancer Treatments and Mutations (13 papers) and Cancer therapeutics and mechanisms (7 papers). Y Takada collaborates with scholars based in Japan, United States and Australia. Y Takada's co-authors include Y Ariyoshi, M. Fukuoka, Satoshi Kudoh, Shunichi Negoro, Kiyoyuki Furuse, Akitoshi Kinoshita, Hidehiko Yamamoto, Yasuhiro Fujiwara, Soichiro Yokota and H Niitani and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Y Takada

30 papers receiving 714 citations

Peers

Countries citing papers authored by Y Takada

Since Specialization

Citations

This map shows the geographic impact of Y Takada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y Takada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y Takada more than expected).

Fields of papers citing papers by Y Takada

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y Takada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y Takada. The network helps show where Y Takada may publish in the future.

Co-authorship network of co-authors of Y Takada

This figure shows the co-authorship network connecting the top 25 collaborators of Y Takada. A scholar is included among the top collaborators of Y Takada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y Takada. Y Takada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Synthesis of O- and N-substituted pentaiodobenzenes bearing σ-symmetric delocalized orbitals using site-selective nucleophilic aromatic substitution reactions 2023 ·Chemistry Letters ·Y Takada, Mao Minoura, Shunsuke Furukawa, Masaichi Saito	0
2	Nutrition Education Reduce Daily Variation of Rectal Volume and Dose in Patients with Prostate Cancer Treated with Intensity-Modulated Radiation Therapy 2018 ·International Journal of Radiation OncologyBiologyPhysics ·Y Takada, M. Takagi, Masanori Someya, Toshihiro Kobayashi, Koichi Aizawa, (unknown), (unknown), (unknown), Toshiki Komatsu, Yuji Yaegashi, Koichi Sakata, Hajíme Ikeda	1
3	Phase III trial of docetaxel plus gemcitabine versus docetaxel in second-line treatment for non-small-cell lung cancer: results of a Japan Clinical Oncology Group trial (JCOG0104) 2009 ·Annals of Oncology ·Koji Takeda, Shunichi Negoro, Tomohide Tamura, Yutaka Nishiwaki, Satoshi Kudoh, Soichiro Yokota, Kunihiko Matsui, Hiroshi Semba, Kazuhiko Nakagawa, Y Takada, Masahiko Ando, Taro Shibata, Nagahiro Saijo	57
4	Predictive factors associated with prolonged survival in patients with advanced non-small-cell lung cancer (NSCLC) treated with gefitinib 2007 ·British Journal of Cancer ·Miyako Satouchi, Shunichi Negoro, Yasuhiro Funada, Yoshiko Urata, (unknown), Shin‐ichiro Yoshimura, Yoshikazu Kotani, Takahiko Sakuma, Hiroshi Watanabe, Shuji Adachi, Y Takada, Yasushi Yatabe, Tetsuya Mitsudomi	35
5	Intestinal MDR1/ABCB1 level at surgery as a risk factor of acute cellular rejection in living-donor liver transplant patients 2006 ·Clinical Pharmacology & Therapeutics ·Satohiro Masuda, Maki Goto, S. Fukatsu, Miwa Uesugi, Yasuhiro Ogura, Fumitaka Oike, Tetsuya Kiuchi, Y Takada, Kouichi Tanaka, Ken‐ichi Inui	40
6	Irinotecan and etoposide for previously untreated extensive-disease small cell lung cancer: A phase II trial of West Japan Thoracic Oncology Group 2005 ·Lung Cancer ·Satoshi Kudoh, Satoaki Nakamura, Takashi Nakano, K. Komuta, Tomohiko Isobe, Nobuyuki Katakami, Y. Fukuda, Y Takada, M Takada, M. Fukuoka, Y Ariyoshi	11
7	P-774 Phase II study of cisplatin plus etoposide with concurrent thoracic radiotherapy (TRT) followed by innotecan plus cisplatin in limited stage small-cell lung cancer (SCLC); A West Japan Thoracic Oncology Group Trial 2005 ·Lung Cancer ·Tatsuhiko Kashii, Hiroshi Saito, Shunichi Negoro, Y Takada, Y. Ichinose, Kunihiko Matsui, (unknown), Keita Tamura, Y Ariyoshi, M. Fukuoka	1
8	Phase I–II study of amrubicin and cisplatin in previously untreated patients with extensive-stage small-cell lung cancer 2005 ·Annals of Oncology ·Yuichiro Ohe, Shunichi Negoro, Kunihiko Matsui, Kazuhiko Nakagawa, T Sugiura, Y Takada, Yutaka Nishiwaki, Soichiro Yokota, Minoru Kawahara, Nagahiro Saijo, M. Fukuoka, Y Ariyoshi	73
9	Pharmacodynamic analysis of tacrolimus and cyclosporine in living-donor liver transplant patients 2005 ·Clinical Pharmacology & Therapeutics ·Masahide Fukudo, Ikuko Yano, Satohiro Masuda, (unknown), Toshiyuki Katsura, Yasuhiro Ogura, Fumitaka Oike, Y Takada, Kohichi Tanaka, Ken‐ichi Inui	66
10	A randomized phase II study of carboplatin/gemcitabine (CG) versus vinorelbine/gemcitabine (VG) in patients with advanced non-small cell lung cancer (NSCLC); mature results of West Japan Thoracic Oncology Group (WJTOG) 0104 2004 ·Journal of Clinical Oncology ·Tatsuhiko Kashii, Nobuyuki Yamamoto, Y Takada, Shunichi Negoro, Kunihiko Matsui, Yoshitsugu Horio, M Takada, Yoichi Nakanishi, (unknown), M. Fukuoka	5
11	The impact of an independent response evaluation committee (REC) using RECIST guidelines in a Four-Arm Cooperative Study (FACS) for advanced non-small cell lung cancer (NSCLC) in Japan 2004 ·Journal of Clinical Oncology ·H. Watanabe, Ryuji Ieki, Kiyoshi Mori, Y Takada, Yutaka Nishiwaki, Y Ariyoshi, Nagahiro Saijo, M. Fukuoka	2
12	Randomised phase III trial of irinotecan combined with cisplatin for advanced non-small-cell lung cancer 2003 ·British Journal of Cancer ·(unknown), Shunichi Negoro, N Masuda, Y Takada, (unknown), Satoshi Kudoh, Nobuyuki Katakami, Y Ariyoshi, Yasuo Ohashi, H Niitani, M. Fukuoka	121
13	Preoperative Marking by Bronchoscopic Dye Injection for a Non-palpable Small Pulmonary Lesion With Ground-Glass Attenuation: A Case Report. 2001 ·Haigan ·(unknown), (unknown), (unknown), Y Takada, (unknown), (unknown)	4
14	Phase II study of irinotecan combined with cisplatin in patients with previously untreated small-cell lung cancer. West Japan Lung Cancer Group. 1998 ·Journal of Clinical Oncology ·Satoshi Kudoh, Yasuhiro Fujiwara, Y Takada, Hidehiko Yamamoto, Akitoshi Kinoshita, Y Ariyoshi, Kiyoyuki Furuse, M. Fukuoka	139
15	[Endoscopic findings of esophagitis in concurrent chemo-radiotherapy for lung cancer]. 1998 ·PubMed ·Hidemi Watanabe, Seiichi Hirota, Toshinori Soejima, (unknown), (unknown), Yoshitaka Hishikawa, (unknown), Y Takada	1
16	[Two patients with mediastinal parathyroid cysts]. 1997 ·PubMed ·Hiroko Hirano, (unknown), Noriaki Tsubota, (unknown), Y Takada	6
17	Randomized study of vinorelbine (VRB) versus vindesine (VDS) in previously untreated stage IIIB or IV non-small-cell lung cancer (NSCLC) 1996 ·Annals of Oncology ·Kiyoyuki Furuse, M. Fukuoka, Mutsuo Kuba, (unknown), (unknown), Shunichi Negoro, Nobuyuki Katagami, Y Takada, (unknown), Mutsuto Kawahara, Kazuo Kubota, Akimasa Sakuma, H Niitani	29
18	[A case of spontaneous pneumomediastinum in a trombonist]. 1989 ·PubMed ·Sadayoshi Ito, Y Takada, A. Tanaka, Naoki Ozeki, Y. Yazaki	10
19	[Radioiodide therapy in pulmonary metastasis of differentiated thyroid cancer--factors affecting the success of I-131 therapy]. 1987 ·PubMed ·Y Takada, Y. Ohta, Shin-ichiro Kawasaki, (unknown), (unknown), Kiyoko Kusakabe, Akiko Shigeta, Toshio Yamazaki, Yohei Fujimoto	1
20	[Clinical and experimental studies on a new intrabronchial infusion therapy of immunopotentiator-OK-432 in lung cancer]. 1986 ·PubMed ·(unknown), Saeko Hirota, Yoshinari Imajo, (unknown), (unknown), Toshinori Soejima, Y Takada, Shinya Kimura, Noriaki Tsubota	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact